Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Creo Medical ( (GB:CREO) ) has issued an update.
Creo Medical announced significant advancements in its operations and financial performance. The company has initiated clinical studies for its MicroBlate Flex device and reported improved operating efficiency with a 24% reduction in costs. The strategic sale of a 51% stake in CME to Micro-Tech has strengthened their commercial platform and balance sheet. Despite a decrease in total sales, the company has achieved a 40% increase in revenue from continuing operations, reflecting wider clinical adoption of its products. The outlook remains positive with expectations of strong revenue growth and self-sustaining cashflows.
The most recent analyst rating on (GB:CREO) stock is a Hold with a £12.50 price target. To see the full list of analyst forecasts on Creo Medical stock, see the GB:CREO Stock Forecast page.
Spark’s Take on GB:CREO Stock
According to Spark, TipRanks’ AI Analyst, GB:CREO is a Neutral.
Creo Medical’s overall stock score is primarily impacted by its weak financial performance, characterized by declining revenues and persistent losses. The technical analysis provides a mixed outlook with some short-term positive signals, but the valuation remains poor due to negative earnings. The absence of earnings call data and corporate events means these factors do not influence the score.
To see Spark’s full report on GB:CREO stock, click here.
More about Creo Medical
Creo Medical is a company operating in the medical technology industry, focusing on advanced energy devices for the treatment of cancer. Their primary products include the MicroBlate technology, designed for tumor ablation in various cancers such as lung, pancreatic, liver, kidney, and bladder. The company is committed to improving cancer treatment and has a market focus on expanding the clinical adoption of their innovative medical devices.
Average Trading Volume: 454,151
Technical Sentiment Signal: Strong Sell
Current Market Cap: £50.01M
Find detailed analytics on CREO stock on TipRanks’ Stock Analysis page.